GONUTS has been updated to MW1.31 Most things seem to be working but be sure to report problems.
PMID:21246541
| Citation |
Yakimchuk, K, Roura-Mir, C, Magalhaes, KG, de Jong, A, Kasmar, AG, Granter, SR, Budd, R, Steere, A, Pena-Cruz, V, Kirschning, C, Cheng, TY and Moody, DB (2011) Borrelia burgdorferi infection regulates CD1 expression in human cells and tissues via IL1-β. Eur. J. Immunol. 41:694-705 |
|---|---|
| Abstract |
The appearance of group 1 CD1 proteins (CD1a, CD1b and CD1c) on maturing myeloid DC is a key event that converts myeloid DC to effective lipid APC. Here, we show that Borrelia burgdorferi, the causative agent of Lyme disease, triggers appearance of group 1 CD1 proteins at high density on the surface of human myeloid DC during infection. Within human skin, CD1b and CD1c expression was low or absent prior to infection, but increased significantly after experimental infections and in erythema migrans lesions from Lyme disease patients. The induction of CD1 was initiated by borrelial lipids acting through TLR-2 within minutes, but required 3 days for maximum effect. The delay in CD1 protein appearance involved a multi-step process whereby TLR-2 stimulated cells release soluble factors, which are sufficient to transfer the CD1-inducing effect in trans to other cells. Analysis of these soluble factors identified IL-1β as a previously unknown pathway leading to group 1 CD1 protein function. This study establishes that upregulation of group 1 CD1 proteins is an early event in B. burgdorferi infection and suggests a stepwise mechanism whereby bacterial cell walls, TLR activation and cytokine release cause DC precursors to express group 1 CD1 proteins. |
| Links |
PubMed PMC3082368 Online version:10.1002/eji.201040808 |
| Keywords |
Antigens, CD1/metabolism; Borrelia burgdorferi/immunology; Dendritic Cells/immunology; Erythema Chronicum Migrans/immunology; Glycoproteins/metabolism; Granulocyte-Macrophage Colony-Stimulating Factor/pharmacology; Humans; Interleukin-1beta/metabolism; Lipids/immunology; Lyme Disease/immunology; Monocytes/drug effects; Monocytes/immunology; Recombinant Proteins/pharmacology; Signal Transduction/immunology; Skin/immunology; Toll-Like Receptor 2/metabolism; Up-Regulation |
| edit table |
Significance
Annotations
| Gene product | Qualifier | GO Term | Evidence Code | with/from | Aspect | Extension | Notes | Status |
|---|---|---|---|---|---|---|---|---|
| GO:0010628: positive regulation of gene expression |
ECO:0000314: |
P |
Figure 3. Different conditioned supernatants were screened to identify the agent that induced CD1 expression. |
complete | ||||
See also
References
See Help:References for how to manage references in GONUTS.
